Erik Walum
7Patents
3h-index
7Co-inventors
50Inventor score
Filing activity: Nov 10, 1982 → May 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5851800A | Process for producing a protein | Human Necessities | 50 | Expired |
| US4530907A | Perfusion-cultivation of animal cells and equipment therefor | Physics | 9 | Expired |
| US6001578A | Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity | Emerging Cross-Sectional Technologies | 7 | Expired |
| US10195167B2 | Compounds for use in the treatment of conditions associated with NADPH oxidase | Human Necessities | 1 | Active |
| US9687490B2 | Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase | Chemistry; Metallurgy | 0 | Active |
| US12202790B2 | Sulfonamide derivatives having selective Nox inhibiting activity | Chemistry; Metallurgy | 0 | Active |
| US10173988B2 | N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.